Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT?
Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash
This article compares two healthcare ETFs: Invesco's S&P 500 Equal Weight Health Care ETF (RSPH) and First Trust NYSE Arca Biotechnology Index Fund (FBT). FBT has shown higher 1-year returns and is a concentrated play on biotechnology, while RSPH offers broader healthcare exposure with lower costs and less volatility.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.